SAN JOSE, Calif. & JERUSALEM Accellix, Inc. is pleased to announce the appointment of Nir Nimrodi as Chairman and Chief Executive Officer effective immediately. Mr. Nimrodi has served as the Executive Chairman of Accellix since June 2019. Mr. Nimrodi commented, “I joined Accellix as Executive Chairman in June of 2019, and after seven months of […]
Additional Resources Will Support New Product Development and Global Expansion Salt Lake City, Utah, USA. Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has closed a $6M round of financing led by Ballast Point Ventures with participation from current investor, Telegraph Hill Partners. The additional funding will support the continued adoption of the […]
Cambridge, United Kingdom – Congenica, a digital health company enabling rapid analysis of complex genomic data to improve disease characterization and diagnosis, today announced the launch of Congenica Neuro™, a new application on its clinical decision support platform that facilitates faster, more accurate and comprehensive characterization and diagnosis of epilepsy and neurodevelopmental disorders. Collectively, around 300 million people […]
Ann Arbor, Mich., and Beijing, China — Celsee, Inc., a leading provider of single-cell isolation technology, and Kindstar Global, the largest medical esoteric testing service group in China, today announced a purchase agreement to provide scientists at the Kindstar Laboratory System in China with Celsee’s Genesis System for monitoring circulating tumor cells (CTCs) in lung, […]
Pictured Thiolated Hyaluronic Acid Kits for 3D Hydrogels. Advanced BioMatrix acquires HyStem® technology for R&D market Technology highly synergistic with existing Advanced BioMatrix products Advanced BioMatrix to fully manufacture and distribute the HyStem® kits California, USA – Advanced BioMatrix has acquired the HyStem® line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan. HyStem® […]
BEVERLY, Mass. — seqWell has announced the close of a $9M Series B financing round with the goal of rapidly expanding its portfolio of genomics products into new areas such as single-cell genomics and transcriptomics. The company continues to drive its plexWell™ multiplexed library prep product offerings in growing markets such as high-throughput low-pass and targeted genotyping. […]
SureSeq™ CLL + CNV – comprehensive CLL genomic profiling from a single assay Oxford, UK – 14 January 2020. Oxford Gene Technology (OGT), A Sysmex Group Company, is excited to announce the launch of its SureSeq CLL + CNV Panel — the company’s latest high-quality, next-generation sequencing (NGS) offering for research into Chronic Lymphocytic Leukaemia (CLL). The SureSeq CLL + […]
Company continues to advance academic and industry access to precise CRISPR-based synthetic reagents for rapid clinical research and development across disease areas REDWOOD CITY, California – Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice (GMP) standards to provide academic and industry partners with high-quality reagents for use in clinical research and development […]
ANN ARBOR, Mich. — Swift Biosciences, Inc. (“Swift”), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift’s DNA and RNA library preparation products in Europe and Asia Pacific markets. With […]
KITCHENER, ON – Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that it has raised $10 million in Series A financing. The funding round was led by Whitecap Venture Partners with participation from existing investors, including Garage Capital, MaRS IAF, Laurier Startup Fund, University of Waterloo Student Venture Fund, and others. […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
